LifeArc appoints Head of Seed Funds
David Holbrook has been appointed to manage our newly created Seed Fund. The £25m fund will invest in innovative early stage therapeutics and biological research aiming to deliver new treatments for patients.
23 January 2018
New partnership in artificial intelligence and machine learning for target discovery announced